β-glucuronidase facilitates binding to estrogen receptors, and the activation of these receptors increases the number of cells in the G0/G1 phase of the cell cycle, promoting proliferation, a process well described in breast cancer, highlighting the relationship existing between gut microbiota and estrogen levels in breast cancer. Here, ESR1 is linked to breast carcinoma.